文献速递头颈部肿瘤放疗放疗物理与技术

头颈部癌症患者中1.5 T磁共振直线加速器与磁共振模拟定位设备上扩散加权MRI序列的体内与体模重复性及再现性的前瞻性评估

Prospective evaluation of in vivo and phantom repeatability and reproducibility of diffusion-weighted MRI sequences on 1.5 T MRI-linear accelerator (MR-Linac) and MR simulator devices for head and neck cancers.
PubMed 文献 · Radiother Oncol · 2023-05-19

研究在1.5 T磁共振直线加速器(MR-linac)和磁共振模拟定位设备(MR sim)上比较六种扩散加权成像(DWI)序列,纳入10例HPV阳性口咽癌患者和10名健康志愿者,并进行体模测试。结果显示MR-linac的DWI序列表现与MR sim接近,作者认为值得进一步临床验证以用于头颈部癌症的治疗反应评估。

要点

  • 腮腺ADC的重复性/再现性wCV在MR-linac的EPI为5.41%/6.72%,SPLICE为3.83%/8.80%,TSE为5.66%/10.03%。
  • 肿瘤ADC的重复性/再现性wCV在MR-linac的EPI为9.64%/10.28%,SPLICE为7.84%/8.96%,TSE为7.60%/11.68%。
  • 除TSE外,大多数体模样本的ADC偏差在±0.1×10⁻³ mm²/s以内。

核心结论

  • MR-linac的DWI序列表现与MR sim序列接近,值得进一步临床验证以用于头颈部癌症的治疗反应评估。

研究设计与样本

  • 前瞻性技术验证研究,纳入10例人乳头瘤病毒阳性口咽癌患者和10名健康志愿者,在1.5 T MR-linac和1.5 T MR sim上比较六种DWI序列,每人每设备两次扫描 session,每序列每次 session 重复两次,并进行体模测试。

主要发现

  • 腮腺ADC的重复性/再现性wCV在MR-linac的EPI为5.41%/6.72%,SPLICE为3.83%/8.80%,TSE为5.66%/10.03%;在MR sim的EPI为3.44%/5.70%,BLADE为5.04%/5.66%,RESOLVE为4.23%/7.36%。
  • 肿瘤ADC的重复性/再现性wCV在MR-linac的EPI为9.64%/10.28%,SPLICE为7.84%/8.96%,TSE为7.60%/11.68%。
  • 淋巴结ADC的重复性/再现性wCV在MR-linac的EPI为7.80%/9.95%,SPLICE为7.23%/8.48%,TSE为10.82%/10.44%。
  • 体模ADC偏差在大多数样本中位于±0.1×10⁻³ mm²/s以内,但EPI_MR-linac、SPLICE和BLADE分别有13个样本中的2、3、1个偏差更大;TSE不在多数样本偏差范围内。
  • b=0图像的SNR在EPI_MR-linac为87.3,SPLICE为180.5,TSE为161.3,EPI_MR sim为171.0,BLADE为171.9,RESOLVE为130.2。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出MR-linac的DWI序列值得进一步临床验证以用于头颈部癌症的治疗反应评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Diffusion-weighted imaging (DWI) on MRI-linear accelerator (MR-linac) systems can potentially be used for monitoring treatment response and adaptive radiotherapy in head and neck cancers (HNC) but requires extensive validation. We performed technical validation to compare six total DWI sequences on an MR-linac and MR simulator (MR sim) in patients, volunteers, and phantoms. METHODS: Ten human papillomavirus-positive oropharyngeal cancer patients and ten healthy volunteers underwent DWI on a 1.5 T MR-linac with three DWI sequences: echo planar imaging (EPI), split acquisition of fast spin echo signals (SPLICE), and turbo spin echo (TSE). Volunteers were also imaged on a 1.5 T MR sim with three sequences: EPI, BLADE (vendor tradename), and readout segmentation of long variable echo trains (RESOLVE). Participants underwent two scan sessions per device and two repeats of each sequence per session. Repeatability and reproducibility within-subject coefficient of variation (wCV) of mean ADC were calculated for tumors and lymph nodes (patients) and parotid glands (volunteers). ADC bias, repeatability/reproducibility metrics, SNR, and geometric distortion were quantified using a phantom. RESULTS: In vivo repeatability/reproducibility wCV for parotids were 5.41%/6.72%, 3.83%/8.80%, 5.66%/10.03%, 3.44%/5.70%, 5.04%/5.66%, 4.23%/7.36% for EPIMR-linac, SPLICE, TSE, EPIMR sim, BLADE, RESOLVE. Repeatability/reproducibility wCV for EPIMR-linac, SPLICE, TSE were 9.64%/10.28%, 7.84%/8.96%, 7.60%/11.68% for tumors and 7.80%/9.95%, 7.23%/8.48%, 10.82%/10.44% for nodes. All sequences except TSE had phantom ADC biases within ± 0.1x10-3 mm2/s for most vials (EPIMR-linac, SPLICE, and BLADE had 2, 3, and 1 vials out of 13 with larger biases, respectively). SNR of b = 0 images was 87.3, 180.5, 161.3, 171.0, 171.9, 130.2 for EPIMR-linac, SPLICE, TSE, EPIMR sim, BLADE, RESOLVE. CONCLUSION: MR-linac DWI sequences demonstrated near-comparable performance to MR sim sequences and warrant further clinical validation for treatment response assessment in HNC.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. McDonald BA, Salzillo T, Mulder S, et al. Prospective evaluation of in vivo and phantom repeatability and reproducibility of diffusion-weighted MRI sequences on 1.5 T MRI-linear accelerator (MR-Linac) and MR simulator devices for head and neck cancers. Radiother Oncol. 2023. PMID: 37211282. doi:10.1016/j.radonc.2023.109717

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。